Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
Approaches to develop effective drugs to kill cancer cells are mainly focused either on the improvement of the currently used chemotherapeutics or on the development of targeted therapies aimed at the selective destruction of cancer cells by steering specific molecules and/or enhancing the immune re...
Saved in:
Main Authors: | Jessica Castro (Author), Marc Ribó (Author), Maria Vilanova (Author), Antoni Benito (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Zeolites as Carriers of Antitumor Ribonuclease Binase
by: Vera Khojaewa, et al.
Published: (2019) -
Antitumor Macrophage Response to Bacillus pumilus Ribonuclease (Binase)
by: Anna Makeeva, et al.
Published: (2017) -
Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model
by: Olga A. Patutina, et al.
Published: (2019) -
Antitumor and Anti-HIV Agents from Natural Products
Published: (2020) -
Germline variation of Ribonuclease H2 genes in ovarian cancer patients
by: Rahel Polaczek, et al.
Published: (2020)